About: Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $10.41 (-0.53%)
XERS NASDAQ Xeris Pharmaceuticals Inc
Xeris Pharmaceuticals Inc share price
XERS price activity
Last Price
$10.410
Change (24hr)
-0.06 USD (-0.53%)
Volume
553.97K
Volume (4w avg)
-
Open
$10.41
Day Range
$10.41 - $10.41
Previous Close
$10.46
Last Trade
13 Oct, 4:24 pm GMT+0
Delayed
13 Oct, 4:24 pm GMT+0
XERS price performance
Delayed
13 Oct, 4:24 pm GMT+0
XERS Market Signals